Torisel (temsirolimus) Important Safety Information from Wyeth following approval by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 06/01/2009


Problem Or Issue:
Please find attached safety communication from Wyeth in respect of timing and monitoring for infusion/hypersensitivity reactions associated with the administration of TORISEL 25mg/ml concentrate and diluent for solution for infusion.

Imporant Safety Information - Torisel (temsirolimus)

« Back